FDA Inspection
Schmidt, Richard Joseph MD IncSchmidt, Richard Joseph MD Inc – FDA Inspection, Mar 5, 2025
Record Details
This FDA Inspection record concerns Schmidt, Richard Joseph MD Inc, with an inspection on March 5, 2025, issued by the San Francisco District Office, covering biologics.
View Company Profile
ID · 0f0e1c83-9344-4a3a-808c-93daa6fdd34f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1262728
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
4- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
- 21 CFR 1271.55(d)(1)(ii)Results, interpretation of CD screening
- 21 CFR 1271.65(b)(2)Labeled re: biohazard, risks, test results
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Schmidt, Richard Joseph MD Inc
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 20, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 12, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 8, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Schmidt, Richard Joseph MD Inc
- FDA Inspection 1061620 - 2018-07-20
- FDA Inspection 954424 - 2016-01-12
- FDA Inspection 826737 - 2013-04-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.